Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines

Clinical trial NCT02432378 · WITHDRAWN

Trial details

NCT number: NCT02432378
Sponsor: Roswell Park Cancer Institute
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer of Ovary Cancer of the Ovary Neoplasms, Ovarian Ovarian Cancer Ovary Cancer Ovary Neoplasms

Start date: 2015-09-04
Primary completion: 2025-06-19
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.